Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

eniluracil

An orally-active fluoropyrimidine analogue. Eniluracil inhibits dihydropyrimidine dehydrogenase, the rate-limiting enzyme that catabolizes and inactivates 5-fluorouracil (5-FU) in the liver. Co-administration of ethynyluracil permits the oral administration of 5-FU.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	5-ethynyluracil ethynyluracil
Code name:	776C85 ADH300004 GW776 GW776C85
Chemical structure:	5-ethynyl-2,4(1H,3H)-pyrimidinedione

eniluracil

Search NCI's Drug Dictionary